期刊文献+

肝癌病人手术期间不同部位血液AFP mRNA定量检测及其意义探讨 被引量:5

Quantitative analysis of AFP mRNA in portal, hepatic and peripheral venous blood of patients with HCC during liver surgery and its clinical significance
原文传递
导出
摘要 目的 研究肝细胞性肝癌 (HCC)病人手术期间不同部位血液甲胎蛋白信使核糖核酸 (AFPmRNA)的水平变化 ,分析其与临床病理学特征和复发转移的关系。方法  18例HCC和 6例非HCC肝肿瘤病人 ,于切除肿瘤前后抽取门静脉、肝静脉和外周静脉血各 5ml,肝炎、肝硬化病人各 10例取外周血 5ml。应用TaqMan实时定量逆转录 聚合酶链反应 (RT PCR)检测AFPmRNA水平。结果 术前外周血AFPmRNA相对HCC的灵敏度为 72 2 % ,特异性为 76 9% ,准确率为 75 0 %。HCC病人术后各部位血液AFPmRNA水平明显高于术前相应部位水平。血液AFPmRNA水平与肿瘤大小、分化程度、有无肝内播散、包膜完整性以及血清AFP浓度均无关 ,而有门静脉癌栓的病人术后肝静脉血AFPmRNA水平明显高于无癌栓者。术后2个月内复发者 ,术后门静脉和外周静脉血AFPmRNA水平明显高于未复发者。结论 TaqMan实时定量RT PCR法检测HCC病人血液AFPmRNA有较高的敏感性和特异性。手术可能促进部分HCC细胞和肝细胞脱落入血。动态监测外周血AFPmRNA水平对术后早期复发有预测价值。 Objective To study the changes of AFP mRNA expression in portal, hepatic and peripheral venous blood of patients with HCC during liver surgery and explore its relation to clinicopathological features and postoperative occurrence of HCC. Methods Portal, hepatic and peripheral venous blood samples were collected before and after tumor resection in 18 patients with HCC and 6 with non-HCC liver neoplasms. Meanwhile, peripheral blood samples were obtained from 20 patients with hepatitis/cirrhosis. AFP mRNA levels in all blood sample were measured using TaqMan real-time RT-PCR. Clinicopathological information of HCC patients was obtained during the follow-up period of 5-31 months. Results The positivity and levels of AFP mRNA in peripheral blood were significantly lower in patients with hepatitis/cirrhosis than in those with HCC. AFP mRNA was not detected in patients with non-HCC liver neoplasms before resection, while 50% positivity after resection, but the levels were lower than in patients with HCC. In those patients with HCC, the positivity of AFP mRNA in portal, hepatic and peripheral venous blood before resection was 72.2%, 77.8% and 72.2%, respectively, but all 100% after resection. Meanwhile, the levels markedly increased after resection. The levels of AFP mRNA in all blood samples were not correlated with tumor size, histological grade, intrahepatic dissemination, capsule integrity or serum AFP concentration. The levels in tumor-draining hepatic venous blood after resection were higher in HCC patients with portal venous thrombosis than in those without thrombosis. Furthermore, the levels of AFP mRNA in portal and peripheral venous blood after resection were higher in HCC patients who had intrahepatic recurrence in 2 months postoperatively. Conclusions Quantitative analysis of AFP mRNA by TaqMan real-time RT-PCR is a very sensitive and specific method for detecting circulating HCC cells. HCC cells and some hepatocytes are released preoperatively and intraoperatively into the blood circulation, which may potentially be the source of recurrence or metastasis. Sequential quantification of AFP mRNA in peripheral blood may predict impending recurrence, especially in 2 months after operation.
出处 《中华肝胆外科杂志》 CAS CSCD 2003年第6期338-341,共4页 Chinese Journal of Hepatobiliary Surgery
基金 上海市卫生系统百人计划基金 ( 97BR0 2 9) 上海市科技发展基金 ( 9844 190 67) 上海市医学领先专业重点学科基金 ( 983 0 0 1)
关键词 肝癌 甲胎蛋白 信使核糖核酸 定量检测 临床意义 病理学 肿瘤复发 肿瘤转移 手术期间 Carcinoma, hepatocellular a-fetoprotein mRNA Quantitative analysis Neoplastic recurrence Metastasis
  • 相关文献

参考文献10

  • 1Matsumura M, Niwa Y, Kato N, et al. Detection of α-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma. Hepatology, 1994, 20: 1418-1425.
  • 2Higuchi R, Foclder C, Dollinger G, et al. Kenetic PCR: real time monitoring of DNA amplification reaction. Biotechnology,1993,11 : 1026-1030.
  • 3Kumada T, Nakano S, Takeda I, et al. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology, 1997,25 : 87-92.
  • 4Komeda T, Fukuda Y, Sando T, et al. Sensitive detection of circulating hepatoeellular carcinoma cells in peripheral venous blood. Cancer, 1995,75 :2214-2219.
  • 5Kedda MA, Kew MC, Skelton M, et al. Non-specificity of messenger RNA of alphaqetoprotein in peripheral blood in detecting early spread of hepatocellular carcinoma in black Africans. J Gastroenterol Hepatol, 1998,13: 885-891.
  • 6Funaki NO, Tanaka J, Seto SI, et al. Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver. Hepatology, 1997,25 : 546-568.
  • 7Yamanaka N, Okamoto E, Fujihara S, et al. Do the tumor cells of hepatocellular carcinoma dislodge into the portal venous stream during hepatic resection? Cancer, 1992,70:2263-2267.
  • 8Wong IH, Lau WY, Leung T, et al. Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis. Clin Cancer Res, 1999,5:4021-4027.
  • 9Lemoine A, Brieon TL, Salvucei M, et al. Prospective evaluation of eireulating hepatoeytes by alpha-fetoprotein mRNA in humans during liver surgery. Ann Surg,1997,226:43-50.
  • 10Matsumura M, Shiratori Y, Niwa Y, et al. Presence of alphafetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma. J Hepatol, 1999,31 : 332-339.

同被引文献25

  • 1周奇,梁力建,彭宝岗,赵继宗.肝细胞癌病人血浆TF,uPA及uPAR检测的临床意义[J].中华肝胆外科杂志,2004,10(7):469-472. 被引量:2
  • 2Hibi K,Robinson R,Wu L,et al.Molecular detection of genetic alteration in the serum of colorectal cancer patients.Cancer Res,1997,57:1045-1047.
  • 3Herman J,Graff J,Myehanen S,et al.Methylation-specific PCR:a novel PCR assay for methylation status of CPG islands.Proc Natl Acad Sci USA,1996,93:9821-9826.
  • 4Katzenellenbogen RA,Baylin SB,Herman JG.Hypermethylation of the DAP-Kinase CPG island in a common alteration in B-cell malignancies.Blood,1999,93:4347-4353.
  • 5Kaneto H,Sasaki S,Yamamoto H,et al.Detection of hypermethylation of P^16 INK4 gene promotor in chronic hepatitis and cirrhosis associated with hepatitis B and C Virus.Gut,2001,48:372-377.
  • 6Mutsuko M, Naoshi N. Postoperative detection of a-fetoprotein mRNA in blood as a predictor for metastatic recurrence of hepatocellular carcinoma. J Gastroenterol Hepatol, 2001,16:445-451
  • 7Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer, 1997,33 : 787-791.
  • 8Padungsutt P, Thirapagawong C, Senapad S, et al. Accuracy of tissue polypeptide specific antigen (TPS) in the diagnosis of ovarian malignancy. Anticancer Res,2000,20 : 1291-1296.
  • 9Senapad S, Neungton S, Thirapakwong C, et al. Predictive value of the combined serum CA-125 and TPS during chemotherapy and before second-look laparotomy ia epithelial ovarian cancer. Anticancer Res, 2000,20: 1297-1302.
  • 10张捷,陈克林,寇丽筠.肝癌患者外周血AFP mRNA检测的临床追踪观察[J].实用癌症杂志,1998,13(4):257-259. 被引量:2

引证文献5

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部